Physician profile

Umar Mahmood

Interventional Pain Medicine · Victoria, TX

NPI 1346506185

$59,626.96

in general payments reported to CMS, 2019-2025

48 companies · $5,277 in 2025

The $5,277 reported for 2025 was more than what 91% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,764.58
Consulting Fee$7,500.00
Travel and Lodging$5,960.81
Entertainment$361.53

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $18,591.77 2019-2025 Wavewriter Alpha Prime 16, Intracept
Foundation Fusion Solutions, LLC $11,547.30 2021-2025
Abbott Laboratories $7,717.69 2019-2025 Proclaim, Eterna
Si-Bone, INC. $3,839.43 2019-2025
Medtronic, INC. $3,510.32 2022-2025 Synchromedii, Intellis Adaptivestim, Inceptiv
Relievant Medsystems, INC. $2,530.49 2021-2023 Intracept
Painteq LLC $2,281.88 2021-2024 Painteq
Nalu Medical, INC. $1,620.74 2021-2025 Nalu Neurostimulation System
Spinal Simplicity, LLC $934.39 2022-2024 Ha Minuteman G3-R
Nevro Corp. $761.03 2021-2024 Senza
Merz North America, INC. $751.23 2019-2023 Xeomin
Stryker Corporation $731.46 2023 Spinejack
Biotronik Nro, INC. $728.87 2024-2025 Prospera
Vertos Medical, INC. $513.79 2021-2024 Mild Device Kit
Surgentec $487.91 2023 Ion Facet Screw System, Tilink
Show all 48 companies
CompanyGeneral paymentsYearsTop products
Teva Pharmaceuticals USA, INC. $407.42 2019
Pfizer INC. $314.34 2019
Pacira Therapeutics, INC. $275.65 2019
Spr Therapeutics, INC $266.45 2020-2025 Sprint Pns System
Bioventus LLC $227.80 2020-2024 Stimrouter Implantable Kit
Collegium Pharmaceutical, INC. $180.39 2019-2025 Belbuca
Averitas Pharma INC. $148.96 2023-2025 Qutenza
Vertiflex, INC. $124.85 2019
Mml US, INC. $122.46 2021
Horizon Therapeutics Plc $121.77 2019
Allergan, INC. $115.34 2019-2022
Lilly USA, LLC $98.53 2019-2023 Emgality
Saluda Medical Americas, INC. $96.31 2023-2024 Evoke Scs, Evoke
Novartis Pharmaceuticals Corporation $91.37 2019-2021
Daiichi Sankyo INC. $75.32 2019
Amgen INC. $59.62 2019-2021
Stimwave Technologies Incorporated $51.00 2021
Biodelivery Sciences International, INC. $40.58 2019
Merz Pharmaceuticals, LLC $29.79 2024 Xeomin
Tersera Therapeutics LLC $29.28 2019
Grt US Holding, INC. $20.69 2021
Bausch Health US, LLC $18.67 2019
Shionogi INC $17.68 2019
Assertio Therapeutics, INC. $17.52 2019
Medtronic Vascular, INC. $16.85 2019
Zyla Life Sciences, INC. $16.55 2020
Radius Health, INC. $15.61 2021
Scilex Pharmaceuticals INC. $15.42 2019
Abbvie INC. $15.02 2021
Hydrofera LLC $12.48 2022
Medtronic USA, INC. $12.12 2019
Sanofi-Aventis U.S. LLC $11.78 2019
Arbor Pharmaceuticals, INC. $11.04 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Umar Mahmood

$59,626.96

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $5,277 reported for 2025 was more than what 91% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

https://glasscript.com/doctor/2787067/umar-mahmood

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.